These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2964344)

  • 21. Tretinoin microsphere gel in facial acne vulgaris: a meta-analysis.
    Nighland M; Grossman R
    J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s2-8. PubMed ID: 18724648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice.
    Korting HC; Braun-Falco O
    Drugs Exp Clin Res; 1989; 15(9):447-51. PubMed ID: 2534292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical erythromycin vs blank vehicle in a multiclinic acne study.
    Jones EL; Crumley AF
    Arch Dermatol; 1981 Sep; 117(9):551-3. PubMed ID: 6457568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris.
    Pazoki-Toroudi H; Nassiri-Kashani M; Tabatabaie H; Ajami M; Habibey R; Shizarpour M; Babakoohi S; Rahshenas M; Firooz A
    J Dermatolog Treat; 2010 May; 21(3):212-6. PubMed ID: 20394495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation.
    Chalker DK; Lesher JL; Smith JG; Klauda HC; Pochi PE; Jacoby WS; Yonkosky DM; Voorhees JJ; Ellis CN; Matsuda-John S
    J Am Acad Dermatol; 1987 Aug; 17(2 Pt 1):251-4. PubMed ID: 2957398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.
    Lucky A; Jorizzo JL; Rodriguez D; Jones TM; Stewart DM; Tschen EH; Kanof NB; Miller BH; Wilson DC; Loven KH
    Cutis; 2001 Oct; 68(4 Suppl):34-40. PubMed ID: 11845946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris.
    Lesher JL; Chalker DK; Smith JG; Guenther LC; Ellis CN; Voorhees JJ; Shalita AR; Klauda HC
    J Am Acad Dermatol; 1985 Mar; 12(3):526-31. PubMed ID: 3157709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [External erythromycin therapy of acne].
    Schmidt JB; Knobler R; Neumann R; Poitschek C
    Z Hautkr; 1983 Dec; 58(24):1754-60. PubMed ID: 6229931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
    Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
    J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study.
    Kawashima M; Harada S; Loesche C; Miyachi Y
    J Dermatol Sci; 2008 Mar; 49(3):241-8. PubMed ID: 18063345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
    Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
    J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Double-blind group comparison of topical meclocycline, erythromycin and placebo in the treatment of papulo-pustulosa acne].
    Rozman TA; Klövekorn G; Kompa H
    Z Hautkr; 1984 Dec; 59(23):1623-34. PubMed ID: 6240840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combined analysis of 2 randomized clinical studies of tretinoin gel 0.05% for the treatment of acne.
    Webster G; Cargill DI; Quiring J; Vogelson CT; Slade HB
    Cutis; 2009 Mar; 83(3):146-54. PubMed ID: 19363908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Local acne therapy with erythromycin].
    Schmidt JB; Thurner J; Poitscheck C; Christl E
    Z Hautkr; 1982 Jan; 57(2):69-77. PubMed ID: 6461974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acne vulgaris with topically applied erythromycin and tretinoin.
    Mills OH; Kligman AM
    Acta Derm Venereol; 1978; 58(6):555-7. PubMed ID: 83088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical erythromycin for acne vulgaris.
    Hellgren L; Vincent J
    Dermatologica; 1980; 161(6):409-14. PubMed ID: 6452297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topically applied erythromycin in inflammatory acne vulgaris.
    Bernstein JE; Shalita AR
    J Am Acad Dermatol; 1980 Apr; 2(4):318-21. PubMed ID: 6444958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
    Gloor M; Lamerz A; Franke-Hoffman M
    Zentralbl Bakteriol A; 1981 Feb; 248(4):502-8. PubMed ID: 6452774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.